599 filings
DEF 14A
PLX
Protalix BioTherapeutics Inc.
Definitive proxy
29 Apr 24
4:30pm
10-K
2023 FY
PLX
Protalix BioTherapeutics Inc.
Annual report
14 Mar 24
7:03am
8-K
PLX
Protalix BioTherapeutics Inc.
14 Mar 24
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
6:57am
8-K
PLX
Protalix BioTherapeutics Inc.
26 Dec 23
Protalix BioTherapeutics Issues 2024 Letter to Stockholders
6:56am
10-Q
2023 Q3
PLX
Protalix BioTherapeutics Inc.
Quarterly report
6 Nov 23
7:50am
8-K
k1nl2i
6 Nov 23
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results
7:22am
8-K
atc0q2ex1s0eiaq3pcg4
12 Sep 23
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors
6:58am
S-8
w9b qars8ripstqebs1e
11 Aug 23
Registration of securities for employees
4:31pm
8-K
92tl8f0pcqxd8e5f
7 Aug 23
Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results
6:59am
8-K
qjh5biqvy5 ca761
13 Jul 23
Submission of Matters to a Vote of Security Holders
4:41pm
424B3
venay
7 Jul 23
Prospectus supplement
4:30pm
8-K
5cupqsx4me12gw9g
29 Jun 23
Submission of Matters to a Vote of Security Holders
7:24am
DEFA14A
4lm52 ntronoij3cy3
28 Jun 23
Additional proxy soliciting materials
4:30pm
8-K
gx1s60rvg8h17 myj
30 May 23
Protalix BioTherapeutics Issues Letter to Stockholders
7:23am
ARS
vb8xq5uuxol o03k1r9
19 May 23
Annual report to shareholders
4:56pm
8-K
zobta w3c
18 May 23
Results of Operations and Financial Condition
6:57am
8-K
4lk8 mn4l
10 May 23
Other Events
6:25am
8-K
vofrs8s iwtm
5 May 23
Other Events
6:56am